Fagron is creating the future of personalizing medicine. The company strives to make a difference and bring a positive impact in every aspect of its endeavours:
- Enabling accessibility to compounding and personalizing medicine.
- Demonstrating social responsibility, ethical practices, and diversity to benefit the environment and community.
- Driving excellence in their operations, leaving a global imprint.
- Cultivating a collaborative and entrepreneurial working environment where innovation can thrive.
Fagron started its journey in 1990 in the Netherlands and quickly expanded to over 20 countries serving more than 80 locations worldwide, becoming the world’s leading pharmaceutical compounding company. Fagron is listed on Euronext Brussels and Euronext Amsterdam.